Press Release OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission 19 hours ago
Press Release OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal Aug 19
Press Release OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development Aug 11
Press Release OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program Aug 7
Press Release Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform Aug 3
Press Release OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment Jul 31